Presentation:
- Duration: 20-25 minutes
- Every group member should participate in the presentation
- At least one extra paper should be included in the presentation to e.g., show that other groups found the same/opposite results, or the same method can be used in other systems or another method can be used to study the same process etc.
- Points that will be taken into account during evaluations (though not a complete list) are listed here
Discussions:
- The group that is assigned for the discussion is in control of the discussion session, which should last around 10-20 minutes. The presenting group should one week before the presentation send the extra paper to the discussion group. The discussion group should prepare at least 5 questions (multiple choice, yes/no, etc) for PresentersWall and at least 3 open questions to be discussed by the whole class. The questions should be sent to c.kesmir@uu.nl at least 24 hours before the discussion to be able to prepare the PersentersWall session. These questions will be the heart of our discussion, so think carefully.
- The grades on the discussion will be given based on the quality of these questions and how well the discussion session is organized.
Article | Presenting | Discussing | Date | Inhibition of EGFR by Cetuximab | 2 | 9 | 14th of May | van Allen et al | 7 | 10 | 22nd of May | Joswik et al | 12 | 4 | 22nd of May | van Allen et al | 9 | 6 | 24th of May | Joswik et al | 8 | 1 | 24th of May | Milinski et al | 3 | 5 | 29th of May | Hirano et al | 10 | 12 | 29th of May | Milinski et al | 1 | 8 | 31st of May | Hirano et al | 11 | 2 | 31st of May | Sun et al | 6 | 7 | 4th of June | Single et al | 4 | 3 | 18th of June | Allen et al | 5 | 11 | 18th of June | Debate: HPV | 13 & 14 | 15&16 | 19th of June | Debate: HPV | 15 & 16 | 13&14 | 19th of June |